Skip to Main Content

Paper Details

Incorporating cytologic adequacy assessment into precision oncology workflow using telepathology: An institutional experience.
Cancer Cytopathol
3
2021
Tumor, metastatic, metastatic cancer, patients, tumor
Author NameAffiliation
Kentaro Ohara
Kentaro OharaThe Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital
Noah GrecoThe Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital
Brian D Robinson
Brian D RobinsonThe Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital
Rema Rao
Olivier ElementoThe Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital
Olivier ElementoInstitute for Computational Biomedicine
Olivier ElementoThe Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital
Olivier ElementoInstitute for Computational Biomedicine
Juan Miguel Mosquera
Juan Miguel MosqueraThe Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital
Juan Miguel Mosquera
Juan Miguel MosqueraThe Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and New York-Presbyterian Hospital
  • 1 - 14

Datasets